Code Snippets
curl "https://financialdata.net/api/v1/short-interest?identifier=BAX&key=API_KEY"import requests
url = 'https://financialdata.net/api/v1/short-interest?identifier=BAX&key=API_KEY'
response = requests.get(url)
print(response.json())
const url = 'https://financialdata.net/api/v1/short-interest?identifier=BAX&key=API_KEY';
const response = await fetch(url);
const data = await response.json();
console.log(data);
Sample Response
[
{
"trading_symbol": "BAX",
"title_of_security": "Baxter International Inc.",
"market_code": "NYSE",
"settlement_date": "2026-09-30",
"shorted_securities": 24366869,
"previous_shorted_securities": 23227313,
"change_in_shorted_securities": 1139556,
"percentage_change_in_shorted_securities": 4.91,
"average_daily_volume": 8190013,
"days_to_cover": 2.98,
"is_stock_split": false
},
...
]Query Parameters
| Name | Type | Description |
|---|---|---|
| identifier | string | The trading symbol for a security. (e.g., MSFT) |
| offset | integer | (Optional) The initial position of the record subset, which indicates how many records to skip. Defaults to 0. (e.g., 100) |
| format | string | (Optional) The format of the returned data, either JSON or CSV. Defaults to JSON. (e.g., json, csv) |
Endpoint Overview
Short interest represents the number of shares of a company that are currently sold short and have not yet been covered. The short interest ratio, also known as days to cover, represents the number of days it would take for all short-sold shares to be covered or repurchased in the market. Our API provides short interest data for over 15,000 securities. There is a limit of 100 records per API call.
Company Profile
BAXTER INTERNATIONAL INC
NYSE: BAX- Market Cap:$16.00B
- ISIN:US0718131099
- Fiscal Year End:12/31
- CEO:Andrew Hider
- Employees:38000
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion (+2% vs 2022), across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.